CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...